About CAR T-Cell Therapy
CAR T-Cell Therapy (Chimeric Antigen Receptor T-Cell Therapy) is one of the most advanced forms of immunotherapy for cancer. It involves engineering a patient’s own T-cells to target and destroy cancer cells. At Paras Hospital, Darbhanga, we specialize in CAR T-Cell treatment for blood cancers such as lymphoma, leukemia, and multiple myeloma, offering cutting-edge care under expert supervision.
Our oncology team combines FDA-approved CAR T-Cell therapies and clinical trial access to provide new hope for patients with relapsed or refractory cancers.
Can't Find what you are looking for?
All major insurance accepted
What is CAR T-Cell Therapy?
CAR T-Cell Therapy is a breakthrough cancer treatment where a patient’s T-cells are collected, modified in a lab to recognize cancer cells, and infused back into the body. These “supercharged” cells then seek and destroy cancer cells more effectively.
Cancers Treated with CAR T-Cell Therapy:
-
Acute lymphoblastic leukemia (ALL)
-
Diffuse large B-cell lymphoma (DLBCL)
-
Mantle cell lymphoma (MCL)
-
Follicular lymphoma
-
Multiple myeloma
-
Ongoing research for solid tumors
CAR T-Cell Therapy Options at Paras Hospital, Darbhanga
Our cancer immunotherapy specialists offer advanced CAR T-Cell treatment options, including:
FDA-Approved CAR T-Cell Therapies
-
Kymriah (Tisagenlecleucel) for ALL and DLBCL
-
Yescarta (Axicabtagene ciloleucel) for DLBCL
-
Tecartus (Brexucabtagene autoleucel) for mantle cell lymphoma
-
Breyanzi (Lisocabtagene maraleucel) for lymphoma
-
Abecma (Idecabtagene vicleucel) for multiple myeloma
Personalized CAR T-Cell Treatment
Custom-modified T-cells tailored to the patient’s cancer type and genetic profile.
Clinical Trial Access
Opportunities for patients to receive the latest CAR T-Cell therapies under research protocols.
Comprehensive Cancer Care
Supportive treatments including infection control, blood transfusions, and long-term monitoring.
Who Should Consider CAR T-Cell Therapy?
You may be a good candidate if you:
-
Have relapsed or refractory blood cancer (leukemia, lymphoma, multiple myeloma)
-
Did not respond to chemotherapy, radiation, or stem cell transplant
-
Need advanced immunotherapy options for long-term remission
-
Are eligible for CAR T-Cell therapy based on blood tests and overall health evaluation
What to Expect During Treatment
Our CAR T-Cell procedure involves:
-
Consultation & Evaluation: Cancer type, stage, and health assessment.
-
Cell Collection (Leukapheresis): T-cells are extracted from the patient’s blood.
-
Cell Engineering: T-cells are modified in a lab with CAR receptors.
-
Infusion: Modified CAR T-Cells are given back through IV.
-
Recovery & Monitoring: Close observation for side effects like cytokine release syndrome (CRS) or neurotoxicity.
-
Hospital stay is typically 2–3 weeks.
-
Long-term follow-ups ensure cancer remission and safety.
Why Choose Paras Hospital for CAR T-Cell Therapy in Darbhanga?
-
Expert Oncologists & Immunotherapy Specialists with advanced global training.
-
State-of-the-Art Cancer Center equipped for complex cellular therapies.
-
Access to FDA-Approved CAR T-Cell Therapies and clinical trials.
-
Personalized Treatment Plans tailored to cancer type and patient health.
-
Comprehensive Multidisciplinary Care including hematology, oncology, and critical care.
-
Trusted by Patients for ethical, innovative, and result-driven cancer treatment.
Book Appointment for CAR T-Cell Therapy in Darbhanga
Don’t let relapsed or resistant cancer limit your options. At Paras Hospital, Darbhanga, our oncology and immunotherapy team provides advanced CAR T-Cell therapy, offering new hope for patients with blood cancers.
If you’re searching for the best hospital for CAR T-Cell therapy, cancer immunotherapy specialists, or advanced cancer treatment in Darbhanga, visit Paras Hospital today.